* Gohealth Inc GOCO.OQ GOCO.O is expected to show a fall
in
quarterly revenue when it reports results on May 9 for the
period ending January 1 0001
* The Chicago Illinois-based company is expected to report
a
1.6% decrease in revenue to $180.154 million from $183.16
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Gohealth Inc is for a
loss
of 95 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.
* Wall Street's median 12-month price target for Gohealth
Inc is
$20.00, above its last closing price of $10.39.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 2.74 2.73 -0.22 Missed -108.1
Sep. 30 2023 -2.90 -2.90 -2.61 Beat 10
Jun. 30 2023 -2.33 -2.92 -3.27 Missed -12.1
Mar. 31 2023 -1.93 -1.96 -1.12 Beat 42.8
Dec. 1.49 -4.30 -7.00 Missed -626.4
31 2022
Sep. 30 2022 -4.24 -4.30 -3.30 Beat 23.3
Jun. 30 2022 -3.75 -3.38 -2.25 Beat 33.4
Mar. 31 2022 -1.29 -1.33 -1.80 Missed -35.3
This summary was machine generated May 7 at 16:02 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)